Skip to content
My WebMD Sign In, Sign Up
This content is selected and controlled by WebMD's editorial staff and is brought to you by Teva Pharmaceutical Industries Ltd.

The Secret to Feeling Good

Hit MS before it hits you hard. How early treatment makes a difference.

Fighting MS Flare-Ups

How to recognize a flare-up of multiple sclerosis and help prevent relapses.

When Foggy Thinking
Slows You Down

Many people with MS have trouble with reduced concentration and memory. Key therapies can help.

Could Physical Therapy Help You?

Do you have tightness, pain, or weakness in your muscles and joints? It may be time to try physical therapy.

Have You Asked the Right Questions?

Are your doctor visits a blur? Does too much info jam your mind? 10 key questions to ask next time.

MS Poll

How are you treating your MS?

View Results
experience matters

Experience Matters

Learn More

1. COPAXONE® prescribing information.
Teva Neuroscience, Inc.

COPAXONE®(glatiramer acetate injection) is indicated for the reduction of the frequency of relapses in relapsing-remitting multiple sclerosis, including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

Important safety information about COPAXONE®

  • The most common side effects of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These reactions are usually mild and seldom require professional treatment. Be sure to tell your doctor about any side effects
  • Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems
  • A permanent indentation under the skin at the injection site may occur, due to a local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes
  • After you inject COPAXONE®, call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, severe pain at the injection site or other uncomfortable changes in your general health. Do not give yourself any more injections until your doctor tells you to begin again

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/Safety/MedWatch, or call 1-800-FDA-1088.

COP139920309/130526

Prescribing Information
Copaxone co-pay solutions

COPAXONE
Co-pay Solutions™

Learn More

* Certain limits and restrictions apply.

Terms and Conditions: COPAXONE Co-pay Solutions™ is open to both new and existing patients who are residents of the US or Puerto Rico and who have private insurance coverage. The offer is not valid for patients covered in whole or in part by Medicaid, Medicare, TRICARE, or any other federal or state government pharmaceutical assistance plan or program (regardless of whether a specific prescription is covered), or by private health benefit programs that reimburse for the entire cost of prescription drugs. Use of this offer must be consistent with the terms of any drug benefit provided by a health insurer, health plan, or private third-party payor. This offer is void where prohibited by law, taxed, or restricted. No additional purchase is required. This offer is valid only at participating pharmacies and may be changed or discontinued at any time without notice. This program is not health insurance.

COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd.
Shared Solutions® is a registered trademark of Teva Neuroscience, Inc.
COPAXONE CO-PAY SOLUTIONS™ is a trademark of Teva Pharmaceutical Industries Ltd.
© 2013 Teva Neuroscience, Inc. COP139920310/130527

shared solutions 24 7 support

Shared Solutions®: 24/7 Support

Learn More

COPAXONE®(glatiramer acetate injection) is indicated for the reduction of the frequency of relapses in relapsing-remitting multiple sclerosis, including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

Important safety information about COPAXONE®

  • The most common side effects of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These reactions are usually mild and seldom require professional treatment. Be sure to tell your doctor about any side effects
  • Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems
  • A permanent indentation under the skin at the injection site may occur, due to a local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes
  • After you inject COPAXONE®, call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, severe pain at the injection site or other uncomfortable changes in your general health. Do not give yourself any more injections until your doctor tells you to begin again

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/Safety/MedWatch, or call 1-800-FDA-1088.

COP139920311/130528

Prescribing Information
Previous Slide
1 of 1
Next Slide
close

From Our Sponsor

Content under this heading is from or created on behalf of the named sponsor. This content is not subject to the WebMD Editorial Policy and is not reviewed by the WebMD Editorial department for accuracy, objectivity or balance.